ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.340
+0.070 (5.51%)
At close: May 12, 2025, 4:00 PM
1.340
0.00 (0.00%)
After-hours: May 12, 2025, 7:46 PM EDT
ADC Therapeutics Stock Forecast
ADCT's stock price has decreased by -68.84% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 7.75, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 478.36% from the current stock price of 1.34.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for ADC Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +422.39% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +497.01% | Mar 31, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +497.01% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +497.01% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
75.67M
from 70.84M
Increased by 6.82%
Revenue Next Year
89.71M
from 75.67M
Increased by 18.56%
EPS This Year
-1.65
from -1.62
EPS Next Year
-1.36
from -1.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 84.5M | 122.4M | 187.6M | ||
| Avg | 75.7M | 89.7M | 152.2M | ||
| Low | 68.2M | 71.1M | 127.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.3% | 61.8% | 109.1% | ||
| Avg | 6.8% | 18.6% | 69.7% | ||
| Low | -3.7% | -6.0% | 42.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.32 | -0.90 | -0.66 |
| Avg | -1.65 | -1.36 | -0.98 |
| Low | -2.21 | -2.05 | -1.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.